Search
Search Results
##search.searchResults.foundPlural##
-
-
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1400PDF: 896Suppl. Files: 452HTML: 233 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1362HTML: 388PDF: 814 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1109PDF: 483HTML: 227 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
934PDF: 510HTML: 191 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4348PDF: 904HTML: 1322Table1: 179 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1274PDF: 932HTML: 89 -
Parvovirus B19-triggered acute hemolytic anemia and thrombocytopenia in a child with Evans syndrome
3514PDF: 980HTML: 423Table 1.: 225 -
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
1040PDF: 375HTML: 88 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1555PDF: 599HTML: 187 -
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1612PDF: 896HTML: 1871Untitled: 194Untitled: 178 -
I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS
1130PDF: 472HTML: 314 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3593PDF: 1105HTML: 23334 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2129PDF: 1320HTML: 3499 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3292PDF: 1310HTML: 6187 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2802PDF: 944HTML: 7330 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1520PDF: 387HTML: 206 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1189PDF: 502HTML: 213 -
Mantle cell lymphoma relapsing at the lymphedematous arm.
1688PDF: 691HTML: 3795 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2787PDF: 1003HTML: 5518 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2164PDF: 2000HTML: 169 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2208PDF: 937HTML: 6782Figure 1: 169







